Cargando…

Epcoritamab-bysp (Epkinly) – A phenomenal breakthrough in the treatment of diffuse large B-cell lymphoma

Detalles Bibliográficos
Autores principales:	Riaz, Rumaisa, Khan, Afsheen, Siddiqui, Tasmiyah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392166/ https://www.ncbi.nlm.nih.gov/pubmed/37534337 http://dx.doi.org/10.1177/20363613231193566

Ejemplares similares

Elrexfio™ (elranatamab-bcmm): The game-changer in treatment of multiple myeloma
por: Rais, Taruba, et al.
Publicado: (2023)

Novel breakthrough in the treatment of sphingomyelinase deficiency
por: Sultan, Wania, et al.
Publicado: (2023)

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma
por: Fan, Kenneth C., et al.
Publicado: (2019)

Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma
por: Papoudou-Bai, Alexandra, et al.
Publicado: (2018)

A Case of Cutaneous Diffuse Large B-cell Lymphoma
por: Çetin, Bülent, et al.
Publicado: (2014)

P1214: SUBCUTANEOUS EPCORITAMAB + R-CHOP FOR FIRST-LINE TREATMENT OF PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: PHASE 1/2 UPDATE
por: Clausen, M. R., et al.
Publicado: (2022)

Phenomenally Large and Small Babies
Publicado: (1889)

Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma
por: Matsuo, Toshihiko, et al.
Publicado: (2018)

EBV-Related Diffuse Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma
por: Şimşek, Cem, et al.
Publicado: (2019)

Cytological diagnosis of primary cardiac diffuse large B cell lymphoma
por: Charfi, Slim, et al.
Publicado: (2013)

Skeletal Muscle Diffuse Large B-Cell Lymphoma in the Gluteal Region
por: Gonzalez-Benavides, Nereyda, et al.
Publicado: (2018)

P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT
por: Wahlin, B. E., et al.
Publicado: (2022)

“A beacon of hope for relapsed multiple myeloma patients: TALVEY™”
por: Khaliq, Nawal, et al.
Publicado: (2023)

Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma
por: Peña, Camila, et al.
Publicado: (2020)

Diffuse large B cell lymphoma with high M protein: an unusual finding
por: Dang, Manavi, et al.
Publicado: (2015)

Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass
por: Öneç, Birgül, et al.
Publicado: (2016)

Synchronous diffuse large B-cell lymphoma of the small intestine and adenocarcinoma of the colon
por: Yang, Ji Hyun, et al.
Publicado: (2018)

Vorasidenib: A promising therapeutic breakthrough for diffuse isocitrate dehydrogenase mutant gliomas
por: Wahid, Abdul, et al.
Publicado: (2023)

P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY
por: Ip, Andrew, et al.
Publicado: (2023)

Semimechanistic Physiologically‐Based Pharmacokinetic/Pharmacodynamic Model Informing Epcoritamab Dose Selection for Patients With B‐Cell Lymphomas
por: Li, Tommy, et al.
Publicado: (2022)

A controversial conclusion regarding primary extranodal diffuse large B-cell lymphoma
por: Park, Seong Kyu, et al.
Publicado: (2011)

The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
por: Kobayashi, T, et al.
Publicado: (2016)

A Primary Bone Diffuse Large B-Cell Lymphoma with Ocular Adnexal Involvement
por: Eren, Rafet, et al.
Publicado: (2016)

The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab
por: Wang, Lan, et al.
Publicado: (2020)

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021)

Severe Lymphocytosis in a Case of Diffuse Large B-Cell Lymphoma Treated by Ibrutinib
por: Paydaş, Semra, et al.
Publicado: (2021)

Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study
por: Pauly, F, et al.
Publicado: (2016)

Transformation of primary cutaneous follicle centre lymphoma into primary cutaneous diffuse large B-cell lymphoma of other type
por: Petković, Ivan Z., et al.
Publicado: (2017)

Pediatric B-cell Lymphoma, Unclassifiable, With Intermediate Features Between Those of Diffuse Large B-cell Lymphoma and Burkitt Lymphoma: A Report of Two Cases
por: Zhang, Shanxiang, et al.
Publicado: (2015)

Clonal hematopoiesis in diffuse large B-cell lymphoma: clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm
por: Liu, Ying, et al.
Publicado: (2022)

Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma
por: Lee, Ha-young, et al.
Publicado: (2014)

Primary Diffuse Large B-cell Lymphoma of the Breast: A Rare Case and Review of Literature
por: Mehta, Dhruv Pankaj, et al.
Publicado: (2017)

Fibrin-associated diffuse large B-cell lymphoma in a hemorrhagic cranial arachnoid cyst
por: Kirschenbaum, Daniel, et al.
Publicado: (2017)

Integrative genome‐wide chromatin accessibility and transcriptome profiling of diffuse large B‐cell lymphoma
por: Fang, Ying, et al.
Publicado: (2022)

Clinical and laboratory diversity of diffuse large B-cell lymphomas in children with Nijmegen breakage syndrome
por: Pastorczak, Agata, et al.
Publicado: (2023)

Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma - De Novo Occurrence or Transformation
por: Gajendra, Smeeta, et al.
Publicado: (2015)

Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma
por: Huang, Yu, et al.
Publicado: (2017)

P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT
por: Cordoba, R., et al.
Publicado: (2022)

Everolimus for the treatment of CD20+ diffuse large B-cell lymphoma in a renal allograft recipient
por: Kute, V. B., et al.
Publicado: (2012)

Diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia: A single center experience
por: Gogia, Ajay, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r8cg286rrk1oojtp25r0c9i1us